Acadia Healthcare Company, Inc. - Common Stock (ACHC)
Healthcare › Services-Specialty Outpatient Facilities, NEC
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 18% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -56.5%
- Revenue growing at 5% annually
Acadia Healthcare Company, Inc. - Common Stock (ACHC) is a Healthcare company operating in Services-Specialty Outpatient Facilities, NEC, listed on the NASDAQ , with a market capitalisation of $2.6 billion . Key value metrics: P/E ratio 23.8, P/B ratio 1.30, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Acadia Healthcare Company, Inc. - Common Stock — Fundamental Analysis Summary
Acadia Healthcare Company, Inc. - Common Stock (ACHC) is currently trading 18% above its Graham Number of $23.53, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 23.8x.
On financial health, ACHC shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -56.5% (sector average: -20.6%), and elevated leverage with a debt-to-equity ratio of 1.29.
StockPik's composite Value Score for ACHC is 56/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ACHC shows revenue growing at 5% year-over-year, with earnings declining at 531%.